• Tarsus Pharmaceuticals granted Chief Commercial Officer Neera Clase 10,587 stock options on Nov. 3, 2026, expiring Nov. 2, 2036.
• Clase also received 6,678 restricted stock units on the same date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002162845-26-000005), on November 05, 2026, and is solely responsible for the information contained therein.